Stay updated on ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial

Sign up to get notified when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 1 ALD403 study, including its safety, tolerability, and pharmacokinetic objectives, participant criteria, study design, and outcome measures.
    Difference
    49%
    Check dated 2026-11-07T12:30:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer's displayed site revision changed from v3.7.2 to v3.8.0. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:21:51.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:39:20.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:23:48.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:43:27.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The study record area no longer displays the 403 Forbidden message or its Home link and is otherwise blank.
    Difference
    0.5%
    Check dated 2026-10-03T17:40:29.000Z thumbnail image

Stay in the know with updates to ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.